Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Hunting secures $38m of new contracts

(Sharecast News) - Precision engineering firm Hunting said on Monday that its subsea technologies arm had secured a number of new contract wins totalling $38.0m. Hunting said its Enpro business had expanded its end-markets after locking in decommissioning contracts with two clients in the North Sea, totalling roughly $23.0m.

The London-listed group stated its clients would utilise its proprietary solutions for the attic oil recovery phase of these decommissioning projects, which were designed to safely access fluids contained in gravity-based concrete cell structures.It also noted that these awards were part of multi-year decommissioning programmes in the North Sea, with the possibility of further orders being awarded in 2026.

Hunting also revealed it had secured a new order for its titanium stress joints for a project in the Gulf of Mexico, with "a major oil and gas company". It said the order totals approximately $15.0m and represents a new client for this product line.

Chief executive Jim Johnson said: "The progress delivered by our subsea businesses during Q1 2025 demonstrates that our widening product offering accesses the whole lifecycle of an oil and gas field, from first-production to abandonment. Further, with the securing of new titanium stress joint orders with a new client in the Gulf of Mexico, Hunting has demonstrated that our leading riser solution is increasingly being adopted by the majors and large Independents operating in deepwater regions."

As of 0930 BST, Hunting shares were down 1.44% at 309.00p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.